Trial Profile
Efficacy safety trial of telavancin in the treatment of Gram-positive bloodstream infection in cancer patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Telavancin (Primary)
- Indications Bacterial infections; Gram-positive infections
- Focus Therapeutic Use
- 07 Dec 2015 New trial record